The Cost-effectiveness of canagliflozin (Cana) versus Saxagliptin (Saxa) among older Individuals living with type 2 diabetes mellitus (T2dm) In canada

May 1, 2015, 00:00
10.1016/j.jval.2015.03.365
https://www.valueinhealthjournal.com/article/S1098-3015(15)00422-2/fulltext
Title : The Cost-effectiveness of canagliflozin (Cana) versus Saxagliptin (Saxa) among older Individuals living with type 2 diabetes mellitus (T2dm) In canada
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)00422-2&doi=10.1016/j.jval.2015.03.365
First page : A62
Section Title : Diabetes/Endocrine Disorders
Open access? : No
Section Order : 1467
Categories :
Tags :
Regions :
ViH Article Tags :